Chemiluminescence Immunoassay

Chemiluminescence Immunoassay Market May Hit US$ 10.6 billion by 2027

Share This Article

Precedence Research has published a new report titled Chemiluminescence Immunoassay Market Size, Share & Trends Analysis By Product (Consumables, Instruments and Software & Services), By Application (Cardiology, Therapeutic Drug Monitoring, Oncology, Endocrinology, Autoimmune Disease, Infectious Disease and Others), By End-User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies and Others) – Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2020 – 2027″, the global chemiluminescence immunoassay market size is expected to grow US$ 5 Billion by 2027, decelerating at a CAGR of over 2% from 2020 to 2027. The report contains 150+ pages with detailed analysis.

The global chemiluminescence immunoassay market research report gives a brief summary of definitions, size analysis and place of production, sales, applications, types, and major players/key vendors of the chemiluminescence immunoassay industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies. The report provides the overall revenue of the global chemiluminescence immunoassay Market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

Market Estimations:

Market Was Valued In 2019 US$ 5.97 Billion
Market Is Projected To Grow By 2027 US$ 10.6 Billion
Compound Annual Growth Rate (CAGR) 7.6 percent from 2020 to 2027

Immunoassays form an imperative section in diagnostics which mostly deal with scrutinizing antigen-antibody reaction. The spectrum of tests that is analyzed with the help of this technology is widespread and analyzers underneath this technology form the mainstay of clinical chemistry testing. Chemiluminescent immunoassay (CLIA) is a variation of the biochemical technique employed in immunology named standard enzyme immunoassay. They can also be utilized as diagnosis tools in medicine and further finds application in several other plentiful industries. The foremost benefit of this technology comprises sensitivity and its aptitude to be unpretentious by signals in the background. Correspondingly, the analyzers working below this principle are easier in operation and design.

There are various advantages of employing chemiluminescence than other kinds of immunoassay, such as light absorption or fluorescence detection method. This is because this technique is ultra-sensitive and can perceiveminorquantities of the biological molecule.The crucialbenefits of chemiluminescent analytical proceduresexist in the extensive dynamic range, lack of interfering emissions, great signal intensity, fast acquisition of the analytical signal, moresteadiness of reagents and their conjugates, random access, less consumption of reagents, decreased incubation time and total compatibility with immunology assay protocol.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1165

Growth Factors

Enhancements are predictable during years to come with the progress of novel analytical platforms like 2D resolution for chemiluminescence multiplex immunoassay and flow-injection chemiluminescent immunoassay and magnetic nanoparticles chemiluminescence immunoassay. This would probably outcome in supplementary increases in the clinical effectiveness of antibody tests. Influences like intensifying pervasiveness of infectious and chronic diseases, technological progressions in POC testing products, and mounting patient consciousness of POC testing are few of the chief influences fueling the need of immunoassay depending upon POC testing and swift testing around the world. The chemiluminescence immunoassay analyzers market is presently a thriving one, as there has been upsurge in requirement for laboratory automation and alliance to attain competence and precision. Many aspects including great parameters testing in small period of time, huge sample processing capacity, least labor necessity, more throughput, integrated data storage and quality control, integrated validation facility with an aim to advance complete effectiveness and accuracy of tests with decreased incubation period is expected to accelerate the growth of the market throughout the prediction period.

The COVID-19 epidemic has further intensified outlook for the chemiluminescent immunoassay market. Expansion of a peptide-based magnetic CLIA for serological diagnosis is underneath way to that effect. Thus, the global chemiluminescent immunoassay market is predicted to relish an optimistic growth trajectory.

COVID-19 Impact on Chemiluminescence Immunoassay  Market Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the chemiluminescence immunoassay market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Precedence Research’s study predicts gradual recovery for the chemiluminescence immunoassay market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Report Highlights

  • North America led the global market in 2019 with largest market share on account of snowballing occurrence of chronic diseases and better-quality and upgraded healthcare infrastructure
  • Asia Pacific is prospective to be an extremely rewarding market for the chemiluminescence immunoassay and it is anticipated to inflate at a high growth rate throughout the prediction period
  • Hospitals segment reported highest share of the revenue generated in 2019. This growth is attributed to snowballing number of uses of automated CLIA analyzers in oncology, therapeutic drug monitoring and companion diagnostics
  • Emergence of integrated modules of automated CLIA analyzers is prospective to flourish the growth of hospitals segment throughout the estimate period

Regional Snapshots

Geographically, North America led the global CLIA market in 2019 and this tendency is predicted to endure throughout the assessment duration. Noteworthy average selling prices of automated CLIA analyzers, mountingneed from surgeons for technically innovative diagnostic instruments with improved accuracy and specificity, and promising coverage as per the Clinical Laboratory Improvement Amendments for IVD procedures are some of the crucial influences predicted to flourish the growth of the market across the region.

Asia Pacific is set to record exponential progress during near future. Steady implementation of innovative products including CLIA technologies, augmented healthcare spending, intensifying rivalry amongst market players and nationwide and intercontinental authorizations to found new laboratories are crucial growth drivers supporting the growth of the market in Asia Pacific.

Key Players & Strategies

Most of the manufacturers engaged in this CLIA market arena are progressively capitalizing in CLIA-based methods for delivering testing kits to their client base. Major companies operating in the global chemiluminescence immunoassay analyzers market are emphasizing on supervisory endorsements, introduction of novel and technically cutting-edge products and merger, acquisition & cooperative arrangements with other corporations. These tactics are probable to bolster the future prospects of the global chemiluminescence immunoassay market worldwide. The global chemiluminescence immunoassay market is highly consolidated, conquered by few significant market players such as Abbott Laboratories, F. Hoffmann La Roche Ltd., Beckman Coulter, Inc. and Siemens Healthineers.

Market Segmentation

By Product

  • Consumables
  • Instruments
    • Automated
    • Semi-automated
  • Software & Services

By Application

  • Cardiology
  • Therapeutic Drug Monitoring
  • Oncology
  • Endocrinology
  • Autoimmune Disease
  • Infectious Disease
  • Others

By End-use

  • Clinical Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Italy
    • France
    • Rest of EU
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
    • Rest of APAC
  • Middle East & Africa
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East and Africa
  • Latin America
    • Argentina
    • Mexico
    • Brazil
    • Rest of Latin America

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Chemiluminescence Immunoassay Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Chemiluminescence Immunoassay Market

5.1. Covid-19: Chemiluminescence Immunoassay Industry Impact
5.2. Chemiluminescence Immunoassay Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Chemiluminescence Immunoassay Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Chemiluminescence Immunoassay Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Chemiluminescence Immunoassay Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Upsurge in demand for treatment monitoring and precautionary diagnosis
6.1.1.2. Growth in technological advancements in disease diagnosis and COVID19 pandemic
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Chemiluminescence Immunoassay Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Chemiluminescence Immunoassay Market Revenue by Market Players (2015-2020)
7.1.1.2. Chemiluminescence Immunoassay Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product TypeSuppliers
7.1.3.2. List of End-users

Chapter 8. Global Chemiluminescence Immunoassay Market, By Product Type

8.1. Chemiluminescence Immunoassay Market, by Component, 2016-2027
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Software & Services
8.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Chemiluminescence Immunoassay Market, By Application

9.1. Chemiluminescence Immunoassay Market, by Application, 2016-2027
9.1.1. Cardiology
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Therapeutic Drug Monitoring
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Endocrinology
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Autoimmune Disease
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Infectious Disease
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Chemiluminescence Immunoassay Market, By End-user

10.1. Chemiluminescence Immunoassay Market, by End-user, 2016-2027
10.1.1. Clinical Laboratories
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Pharmaceutical & Biotechnology Companies
10.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Chemiluminescence Immunoassay Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast by End-user (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast by End-user (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast by End-user (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by End-user (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by End-user (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)

Chapter 12. Company Profiles

12.1. F. Hoffmann-La Roche AG
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Siemens Healthineers
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Abbott Laboratories
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. DiaSorin S.p.A.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Ortho Clinical Diagnostics
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Immunodiagnostic Systems
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. Beckman Coulter Inc.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Inova Diagnostics, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Maccura Biotechnology Co., Ltd
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1165

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Bloghttps://precedenceresearchnews.wordpress.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →

Leave a Reply

Your email address will not be published. Required fields are marked *